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ABSTRACT Variants of the human angiotensinogen gene
have been linked in some studies to increased circulating
angiotensinogen levels and essential hypertension. To test for
direct causality between genotypes at the angiotensinogen
locus and blood pressures, we have studied mice carrying zero,
one, two, three, or four functional copies of the murine
wild-type angiotensinogen gene (Agt) at its normal chromo-
somal location. Plasma angiotensinogen levels increase pro-
gressively, although not linearly, from zero in the zero-copy
animals to 145% of normal in the four-copy animals. Mice of
all genotypes are normal at birth, but most zero-copy animals
die before weaning. The kidneys of the zero-copy animals show
pathological changes as adults, but the kidneys are normal in
the other genotypes. One adult zero-copy male tested was
fertile. The blood pressures of the one-copy through four-copy
animals show significant and almost linear increases of
approximately 8 mmHg per gene copy despite their normal
compensatory mechanisms being intact. These results estab-
lish a direct causal relationship between Agt genotypes and
blood pressures.
The AGT gene may be important in other hypertensive dis-
eases. Thus, Ward et al. (12) have demonstrated association of
pre-eclampsia with the M235T variant; and Arngrimsson et al.
(13) have found cosegregation of a marker in the 3' flanking
region ofAGTwith pre-eclampsia. These various studies show
that some DNA sequences at or near the AGT locus affect
blood pressure, but direct proof that variants of theAGTgene
cause changes in blood pressure is lacking.
Smithies and Kim have recently described a way of using
gene targeting to analyze quantitative genetic traits in living
animals (14). After identification of a candidate gene, mice
carrying an increased or decreased number of copies of the
candidate gene are generated without altering the chromo-
somal location or regulatory elements of the gene; levels of
gene expression above or below normal can be achieved in this
way. The effects of these quantitative changes on the pheno-
type of interest can then be evaluated in a manner that
eliminates the influences of any other genes (linked or un-
linked). We here apply this approach to establish a direct
causal relationship between Agt genotypes and blood pres-
sures.
Essential hypertension affects about 20% of adults in the
United States. Genetic and environmental factors are impor-
tant in its etiology (1). The renin-angiotensin system is one of
the major systems regulating blood pressure and sodium
balance, and many elements in it are potential determinants of
hypertension. Plasma levels of angiotensinogen (AGT) have
received particular attention for several reasons (2). First,
plasmaAGT levels and diastolic blood pressures are correlated
in some patients (3), and associations of AGT levels and
hypertension have been demonstrated in families (4, 5). Sec-
ond, infusion of AGT into sodium-depleted but not sodium-
repleted rats raises their blood pressures (6), while adminis-
tration of antibodies against AGT lowers pressures (7). Third,
transgenic mice expressing high levels of rat AGT have
elevated blood pressures (8, 9). Fourth, human plasma AGT
levels are near the Km of renin (10), so that variations in AGT
levels will affect the rate at which renin converts AGT to
angiotensin I.
At the genetic level, cosegregation of variants at the human
angiotensinogen locus (AG7) and hypertension has recently
been described. In human hypertensive siblings, Jeunemaitre
et al. (2) showed that a specific variant, M235T, was signifi-
cantly linked to hypertension and was also associated with a
modestly elevated plasma AGT concentration (about 120% of
normal); they accordingly proposed that some variants of the
AGT gene lead to an increase in AGT levels and thereby
eventually to increased blood pressure. Caulfield et al. (11)
have confirmed significant linkage between hypertension and
chromosomal regions including and close to theAGTgene, but
they could not confirm association with the M235T marker.
MATERIALS AND METHODS
Gene Targeting. Cloning of the Agt gene from strain 129
mouse DNA and the use of gene targeting to generate mice
with a tandem duplication of the wild-type gene at its normal
chromosomal location have been described previously (14). To
disrupt the Agt gene, the targeting plasmid illustrated in Fig.
1A was made, using an 8-kb fragment of strain 129 genomic
DNA containing exons 2 and 3 of the gene. The 5' end of the
fragment is aHindIll site in intron 1; the 3' end of the fragment
is an Mbo I site about 1 kb downstream of exon 3. Within exon
2 of the fragment, a Stu I/BamHI region that codes for 114
amino acids (including all angiotensin I-coding sequences) was
replaced with a neomycin-resistance gene driven by the phos-
phoglycerate kinase promoter (16). A copy of the Herpes
simplex thymidine kinase gene was positioned downstream of
the longer arm of homology to allow positive-negative selec-
tion (17). The targeting plasmid was linearized with HindIll
and was electroporated into a subline, BK4, of the embryonic
stem cell line E14TG2a (18), which is derived from mouse
strain 129. The cells were cultured as described (19). Potential
recombinants were identified by a PCR recombinant fragment
assay (15) using the primers a and b illustrated in Fig. 1. Primer
a is 5'-TGCACGGGTTCTGAGGATCCA-3'; b is 5'-TAA-
AGCGCATGCTCCAGACT-3'. Southern blot analysis of cell
DNA digested with Xba I was used to confirm the correct
modification. Targeted cells containing the disruptedAgt gene
were injected into blastocysts to generate male chimeras,
which were then mated with inbred females of strain
C57BL/6J (B6).
Abbreviations: AGT, angiotensinogen; B6, C57BL/6J (mouse strain).
tH.-S.K. and J.H.K. contributed equally to this work.
ITo whom reprint requests should be addressed.
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement" in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
2735
Proc. NatL Acad Sci USA 92 (1995)
5kb






vv I vim I I r











H X H X S SH
Targeted 1 'I'v IllZ v v
Locus 1 a,- -'b 3 45
Eprobe
H H S S H H S SH




c 1 2 3 4 5 6
- - - /.0/ kba* I-S kb
.1/1%J %M 1/o1/ 2/0
Sac l
7 8 9 10 11 12
* *4W604 0-Skb
40% ,0043kb
1/1 1/1 2/1 2,12/22/2
FIG. 1. (A) Targeted disruption of the mouseAgt gene. Exons 1 to
5 are shown as black boxes. Relevant restriction sites are HindIII (H),
Sac I (S), and Xba I (X). A selectable marker gene conferring
neomycin resistance was inserted into exon 2 at the same time as
deleting the DNA coding for 114 amino acids of the mature AGT
protein, including all angiotensin I-coding sequences and 17 amino
acids of the leader. Arrowheads a and b indicate primers that, after
PCR, yield a 1.2-kb fragment diagnostic of targeting (15). (B) Targeted
duplication of the mouse Agt gene (14). Horizontal brackets indicate
the duplicated region. (C) Southern blots of tail DNA from animals
of the six Agt genotypes. Samples 1-6 were digested with Xba I;
samples 7-12, with Sac I. The black squares inA andB indicate the two
probes used.
F1 progeny heterozygous for the disrupted Agt gene (1/0)
and for the duplicated Agt gene (2/1) were mated to generate
F2 animals with all possible Agt genotypes.
Genotypes of Mice. Genotypes were determined by South-
ern blots ofXba I- or Sac I-digested tail DNA or by PCR with
primers a and b (Fig. 1), except that 2/1 and 2/2 were
distinguished by scoring for a simple sequence polymorphism,
D8MIT56 (20), linked to the Agt locus (see Results and
Discussion). To do this, PCR of tail DNA was performed with
the published primers (20); PCR was followed by acrylamide
gel electrophoresis to determine the presence of a 182-bp
fragment characteristic of strain 129 and/or a 162-bp fragment
characteristic of strain B6. The presence of only the 182-bp
fragment or of both fragments was respectively scored as 2/2
or 2/1.
Plasma AGT and Renin Levels. Steady-state plasma AGT
levels were determined by a radioimmunoassay for angiotensin
I as described (14). Renin levels were measured identically,
except that 2 ,ul of plasma from a nephrectomized rat was
added as a source ofAGT in place of 4 ,ul of kidney extract as
a source of renin.
Blood Pressure Measurements. Blood pressures were mea-
sured in young adult mice (mean age 100 days; range 73-134
days) by a noninvasive tail-cuff method and by intra-arterial
catheterization. Krege et al. (21) have described and compared
the methods and have shown that their results are well
correlated. The tail-cuff method uses a four-channel, comput-
erized, automated system designed and built by John E. Rogers
and James P. Rogers (Visitech Systems, Raleigh, NC). After
training sessions on at least 7 days, the tail-cuff systolic blood
pressure for each animal (without the investigator knowing its
genotype) was taken as the mean of blood pressures deter-
mined during at least five subsequent daily sessions. For
intra-arterial blood pressures, carotid catheterization was per-
formed as described (21) while the animals were under general
anesthesia (ketamine 2 mg and xylazine 0.2 mg per 25-30 g of
body weight). At least 4 hr after surgery, blood pressure
waveforms from quietly resting mice were obtained for about
10 min. Mean arterial pressure was calculated as the sum of
two-thirds the mean of all waveform troughs and one-third the
mean of all waveform peaks. Requirements for inclusion of
intra-arterial data were a pulsatile waveform, minimal heart
rate of 500 beats per minute, and survival of the mouse until
the following day. The investigators knew the genotypes of 9
animals used for the intra-arterial measurements but did not
know the genotypes of the other 13 animals; the data obtained
in the "blinded" fashion were indistinguishable from the
combined data, which we present here.
All experiments were conducted in accordance with insti-
tutional guidelines for the University of North Carolina at
Chapel Hill and Duke University Medical Center. Mice were
fed R-M-H 3500 autoclavable chow (Agway, Syracuse, NY).
Kidney Function Studies. Renal plasma flows and glomer-
ular filtration rates were respectively determined from p-
aminohippuric acid (PAH) and inulin clearances as described
(22).
Histological Analysis. Tissues were collected and fixed in
10% neutral-buffered formalin immediately after the animals
were sacrificed. Staining was with hematoxylin and eosin.
RESULTS AND DISCUSSION
Gene Disruption and Gene Duplication by Targeting. We
have used conventional gene targeting in embryonic stem cells
derived from the mouse inbred strain 129 to disrupt the Agt
gene and to delete the nucleotides that encode angiotensin I.
The target gene (23), targeting construct, and resulting chro-
mosome are illustrated in Fig. 1A. A male chimera generated
from one of the targeted embryonic stem cell colonies trans-
mitted the disrupted Agt gene to its offspring.
A method for duplicating genes by gap-repair gene targeting
and its application to the mouseAgt gene have been described
elsewhere (14). Fig. 1B illustrates the resulting chromosome.
The whole of the gene, including all known regulatory se-
quences, is tandemly duplicated at its natural chromosomal
locus together with about 3 kb of DNA 5' to the start of
transcription of the gene and about 200 bp 3' to the poly(A)
addition site. The extent of the duplication is illustrated by the
heavy horizontal brackets in Fig. 1B.
Generation of Animals Having Various Numbers of Func-
tionalAgt Genes. Chimeric males carrying the disrupted or the
duplicatedAgt gene were mated with inbred strain B6 females.
The resulting (129 x B6)F1 mice are genetically identical
except for their Agt genotypes and sexes. Three Agt genotypes
are possible in these F1 animals: 1/0 (one normal and one
disrupted copy), 1/1 (normal), and 2/1 (one duplicated and
one normal copy), corresponding to one, two, and three
functional copies of the Agt gene.
When suitable F1 pairs are bred, three additional Agt
genotypes arise in F2 mice: 0/0 (both copies disrupted), 2/0
(having one chromosome with theAgt gene duplicated and one
with the gene disrupted), and 2/2 (both copies duplicated). All
sixAgt genotypes are distinguishable at the DNA level by using
Southern blots (Fig. 1C) or PCR with the probes and primers
illustrated in Fig. 1. However, Southern blots ofDNA from 2/1
and 2/2 animals differ only in the relative intensities of
autoradiographic bands, unless the diagnostic restriction en-
zyme sites lie outside the (18-kb) duplicated Agt gene region.
We consequently prefer to distinguish these two gen'otypes by
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scoring for a simple sequence fragment, D8MIT56 (20), which
is closely linked to the Agt locus and which differs in length in
strain B6 (160 bp) and strain 129 (182 bp). In our F2 mice, the
singleton Agt gene is always derived from strain B6, and the
duplicated gene is always from strain 129. In the absence of
crossovers, the 2/1 and 2/2 genotypes are therefore distin-
guishable by PCR for the simple sequence; 2/1 animals give
both the 160-bp and the 182-bp fragments; 2/2 animals give
only the 182-bp fragment. Crossovers between the Agt gene
and D8MIT56 will cause errors in this typing procedure.
However, the frequency of such crossovers must be small, since
we have observed none in approximately 90 meioses in which
they would have been identified by observing absence of the
129-derived fragment from animals having the duplicated
gene.
To study the relative survival of pups with different numbers
of functional copies of Agt, we collected data from 39 F1
matings yielding over 240 weanlings. The results showed no
significant deviations from Mendelian expectation in the
survival to weaning of pups with one, two, three, or four
functional copies of the Agt gene, but there was a highly
significant (P < 0.001 by x2) deficiency of 0/0 pups (23
expected, 3 observed). We also found a high proportion of 0/0
pups among the pups that died before weaning. We therefore
sacrificed a litter from a 1/0 x 1/0 cross immediately after
birth and found that the three possible genotypes were rep-
resented in Mendelian proportions (3 were 0/0, 5 were 1/0,
and 2 were 1/1). Thus, absence of a functional Agt gene is
compatible with survival to birth, but postnatal survival is
severely compromised.
Plasma AGT Concentrations Versus Agt Genotype. We have
reported (14) the steady-state plasma AGT levels in (129 x
B6)Fl animals with one, two, and three functional copies of the
Agt gene; they were, respectively, 35%, 100% (by definition),
and 124% that of the normal two-copy (1/1) animals. [The
absolute level of AGT (±SEM) in normal F1 animals is 524 ±
30 nmol/ml.] The F2 generation of animals allows analysis of
zero-copy (0/0) and four-copy (2/2) animals. As expected, the
zero-copy animals (n = 2) have no detectable AGT in their
plasma. Four-copy animals (3 males and 3 females) have an
average AGT level of 144.5% ± 4.7% of the normal two-copy
(1/1, F1) levels.
The F2 generation also includes animals of the 2/0 genotype.
These animals have a duplicatedAgt locus on one chromosome
8 and a disrupted Agt gene on the other. In contrast, normal
(1/1) animals have a singleton Agt gene on each parental
chromosome 8. Comparisons between these two types of
animal are therefore informative with respect to the function
of the duplicated Agt gene. We found the steady-state plasma
AGT levels in 2/0 F2 animals (3 males and 3 females) to be
55.0% ± 1.5% of the normal 1/1 F1 level. The AGT levels of
the 1/0 F1 animals are 35% of normal. Thus, the duplicatedAgt
locus leads to the synthesis of more AGT than does one normal
singleton Agt gene, in confirmation of our earlier F1 studies
(14), but to less than can be achieved with two normal singleton
genes.
Comment is required on the plasma AGT levels of the
one-copy F1 animals, which are 35% of normal, rather than the
50% level expected from a linear relationship between AGT
level and gene copy number. We determined plasma renin
levels in these animals and found them to be 250% ± 5% of
normal (n = 9). This suggests that in these animals a higher
than normal proportion of plasma AGT is being converted to
angiotensin I.
Blood Pressures Versus Agt Genotype. We measured blood
pressures in two ways (21): indirectly by a noninvasive com-
puterized tail-cuff system and directly by catheterization of a
carotid artery. Fig. 2A and B presents the tail-cuff pressures
(23 males and 20 females) and the mean arterial pressures (22
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FIG. 2. Blood pressures versusAgt genotype (1 mmHg = 133 Pa).
(A) Tail-cuff pressures of F2 mice having zero (n = 3), one (n = 11),
two (n = 10), three (n = 8), or four (n = 11) copies of theAgt gene.
(B) Mean arterial pressures of F2 mice having one (n = 7), two (n =
9), three (n = 3), or four (n = 3) functional copies of the Agt gene.
functional Agt genes. The overall picture is clear. Blood
pressures increase with increasing numbers of functional Agt
genes. Several tests establish the statistical significance of
these results. Regression analysis with mean arterial pressure
as the dependent variable shows a highly significant effect of
Agt copy number (correlation coefficient 0.60; slope 8.3 ± 2.3
mmHg per copy; P < 0.01). Regression analysis with tail-cuff
blood pressure as the dependent variable also indicates a
significant effect of Agt copy number (correlation coefficient
0.38; slope 3.7 ± 1.4 mmHg per copy; P < 0.02). Because the
two groups of animals used in these experiments were inde-
pendent, the probability of the combined results occurring by
chance can be calculated from the individual probabilities as
described by Fisher (24); the combined probability is <0.0005.
Inclusion in the tail-cuff group of animals of both sexes
allows the use of two-factor analysis of variance to assess any
effects of gender. This analysis shows that neither gender (P =
0.57) nor the interaction of gender and Agt copy number (P =
0.11) is significantly correlated with tail-cuff blood pressures.
The 2/0 F2 animals had intra-arterial blood pressures (132
± 3 mmHg, n = 4) that did not differ significantly (P > 0.6)
from the pressures of 1/1 F2 animals (129 ± 4 mmHg, n = 9).
Exclusion of the Effects of Linked Genes. Some, although
not all, of our F2 mice differ systematically only at theAgt locus.
The one-copy (1/0) and three-copy (2/1) F2 animals are of this
category. Thus, the wild-typeAgt allele plus neighboring linked
genes in all the one-copy and three-copy F2 animals are derived
from strain B6; their other Agt allele (which differs in being
disrupted or duplicated) plus neighboring linked genes are
derived from strain 129. Analysis of the data from these
one-copy and three-copy F2 animals can therefore be used to
exclude any possible effects of linked genes. (Unlinked genes
segregate randomly in the F2 generation and so do not differ
systematically between these groups of animals.) We find, in
agreement with the results from the complete set of F2
animals, that the one-copy and three-copy F2 animals show the
same effect of Agt gene copy numbers on blood pressures.
Thus, regression analysis of the intra-arterial data from the
one-copy and three-copy F2 animals showed a slope of 8.1 ±
4.0 mmHg per copy, n = 10, P < 0.05; similar analysis of the
tail-cuff data from different one-copy and three-copy F2
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FIG. 3. Renal plasma flow versusAgt genotype. Renal plasma flows
were measured by clearance ofp-aminohippuric acid in F1 mice having
one (n = 6), two (n = 9), or three (n = 6) functional copies of the Agt
gene (genotypes 1/0, 1/1, and 2/1).
animals showed a slope of 7.7 ± 2.1 mmHg per copy, n = 19,
P < 0.001. The combined probability is <0.0005. Therefore,
the demonstrated effects of Agt gene copy number on blood
pressure are independent ofany other genetic differences linked
or unlinked to the locus.
Kidney Function. Because renal function has a strong
impact on blood pressure, we performed renal studies on 1/0
(3 male, 3 female), 1/1 (5 male, 4 female), and 2/1 (3 male, 3
female) F1 mice 208-250 days of age. Renal plasma flows were
measured as clearances of p-aminohippuric acid. Fig. 3 pre-
sents the resulting data. Clearly, renal plasma flows in the 1/0
animals are substantially and significantly increased (P <
0.005) relative to the flows in two-copy (1/1) and three-copy
(2/1) animals, which do not differ significantly. Since the
blood pressures of the 1/0 animals are less than normal, these
findings suggest that their renal vascular resistance is de-
creased relative to normal. As judged by inulin clearances
(data not shown), the one-copy and three-copy mice have the
same glomerular filtration rates as normal two-copy mice.
Zero-Copy Animals. The birth and occasional survival to
adulthood of 0/0 animals completely lacking endogenous
AGT is remarkable in view of the many effects known to be
mediated by angiotensin II. Also, one 0/0 male tested pro-
duced three litters (average 8.3 pups per litter) of normal size,
demonstrating that angiotensin is not essential for male fer-
tility in mice.
The newborn 0/0 animals (n = 2) do not have any obvious
pathological changes, either at the gross level or microscopi-
cally. At present, we cannot determine whether this is because
FIG. 4. Histology of kidneys from normal and zero-copy animals. (x350 inA-D andX175 inE andF.) (A) Normal artery inwild-type kidney.
(B-D) Arteries in zero-copy adult kidneys, showing different degrees of abnormality. (E) Normal cortex in wild-type kidney. (F) Representative
area of pathological cortex from a zero-copy adult kidney.
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endogenous AGT or its products are not required for normal
development or because of transfer of maternally derived
factors across the placenta. The kidneys of adult 0/0 animals
(n = 3, 100-120 days of age) show pathological changes. Fig.
4A shows a normal kidney artery in oblique section. Fig. 4 B-D
presents representative vessels from a 0/0 animal showing
thickened walls caused by an increased number of cells, which
appear disorganized; these changes are most pronounced in
interlobular arteries. This arterial wall thickening in the 0/0
animals could be the result of an as-yet-unknown response to
the absence ofAGT and its products and/or to their low blood
pressures. The kidneys of the 0/0 animals also have general-
ized cortical thinning with focal areas of severe atrophy (Fig.
4F), compared with normal animals (Fig. 4E). The atrophied
areas show shrinkage and loss of tubules, interstitial fibrosis,
and interstitial infiltration of chronic inflammatory cells,
perhaps resulting from inadequate blood flow through arteries
such as in Fig. 4D. The kidneys of the one-, two-, three-, and
four-copy young adult animals (n = 24) appeared normal,
except for one wild-type 90-day-old male that developed an
isolated case of severe glomerulosclerosis.
Conclusions. Our observations on the effects of Agt gene
expression on blood pressures can be summarized as follows.
Plasma steady-state AGT levels increase progressively but not
linearly with Agt gene copy number, ranging from zero in the
zero-copy animals to approximately 145% normal in the
four-copy animals. Tail-cuff systolic pressures and intracarotid
mean blood pressures measured on unanesthetized F2 animals
increase progressively and significantly with increases in the
number of functional Agt gene copies, with a change in mean
arterial pressure of approximately 8 mmHg per copy. The same
progressive change is seen in mice that differ systematically
only at the Agt locus.
These observations lead to the conclusion that different
levels of function of the nativeAgt gene, comparable in relative
degree to those seen in human subjects, directly cause signif-
icant differences in the blood pressures of mice, even though
they have all their homeostatic compensatory systems intact.
The relevance of our findings to hypertension requires com-
ment. As discussed in the introduction, a case could already be
made that sequences at or near the human AGT locus affect
blood pressure and are correlated with AGT levels. Missing
was a direct proof of causality. Our animal data supply this
proof for mice; variants of the mouseAgt gene that alter plasma
AGT levels directly affect blood pressure.
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